Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
HOME > ACADEMIA
ACADEMIA
- Osaka University Hospital to Initiate PET Microdose Study This Fall: Prof. Tomono
April 23, 2013
- New COPD Guidelines Recommend LAMA, LABA on Equal Footing
April 23, 2013
- Japan College of Rheumatology Airs Concerns over Safety of Xeljanz
April 11, 2013
- Kyoto Heart Study Chief Investigator Resigns after Diovan Paper Retractions
March 1, 2013
- Diovan Paper Contained “Careless Errors,” but “No Impact on Findings”: Chief Investigator Comments on Retraction
February 7, 2013
- JSGM Calls for 80% Generic Share, 30% Reduction in NHI Prices of Long-Listed Drugs by End of FY2017
December 6, 2012
- Less than 20% of IRBs Utilize Central IRB Despite Revised GCP Ordinance: Dr Narumoto of Okayama Univ.
December 5, 2012
- Need for Corporate Seminars May Depend on “Doctors’ Abilities”: NIRS Senior Researcher Kurihara
November 30, 2012
- AASD Scientific Meeting Shines Light on SGLT-2 Inhibitors as Next Generation Diabetes Treatment
November 28, 2012
- New Hoshi General Hospital to Give Patients Option of In-House or Legal Prescriptions Starting in January
November 22, 2012
- J-ADNI2 to Go Forward in Search of New Treatment for AD: Prof. Iwatsubo of Univ. of Tokyo
November 19, 2012
- New COPD GLs to Recommend LAMA, LABA Equally: Prof. Nagai of Tokyo Women’s Medical University
October 22, 2012
- Biosimilars Should Be Mentioned in Government Roadmap: JSGM President Muto
October 18, 2012
- Supercomputer to Dramatically Shorten Exploratory Period for Lead Compounds: Prof. Fujitani of University of Tokyo
October 16, 2012
- We Would Like to Provide iPS Cells with Medical History Identification: Prof. Yamanaka of Kyoto University
October 15, 2012
- JAOG Insists on Introduction of HPV Testing to Cervical Cancer Screening
September 14, 2012
- CRND Initiates Clinical Research, Showing Willingness for Company-Sponsored Studies
September 6, 2012
- Incidence of CVD Decreases More in High-Risk Patients with Lower LDL-C during Pravastatin Treatment
July 26, 2012
- 95% of Japanese-Bound Online Drug Sales “Rogue”: LegitScript Survey
July 26, 2012
- Takeda’s TAK-070 for AD Worthy of Clinical Trial: Prof. Iwatsubo of Univ. of Tokyo Hospital
July 18, 2012
ページ
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…